Synapse - Sloan Kettering Institute Postdocs

Results (31)

Targeting of PIM kinases shows single agent efficacy and synergizes with BCL2 inhibitors in diffuse large B cell lymphoma of the ABC subtype

Journal Article

Tarantelli, C.; Kayali, O.; Civanelli, E.; Cascione, L.; Mensah, A. A.; Folloni, C.; Arribas, A. J.; Rinaldi, A.; Cmiljanovic, V.; Mondello, P.; more...
Hematological Oncology (2025)

Fulltext@MSK | Save

Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse

Review

Ghione, P.; Lewis, K. L.; Bobillo, S.; Nayak, L.; Schorb, E.; Nichelli, L.; Ng, A.; Savage, K. J.; McKay, P.; Nastoupil, L.; more...
Hematological Oncology (2024)

Fulltext@MSK | Save

Association between geriatric impairments and quality of life in older adults with lymphoma on oral targeted therapies: A one‐year prospective study

Meeting Abstract

Torka, P.; Akhtar, O.; Kaijar, T.; Wang, K.; Attwood, K.; Carozza, D.; Bouchard, E.; Ghione, P.; Cortese, M.; Wildes, T.; more...
Hematological Oncology (2023)

Fulltext@MSK | Save

Primary hepatic lymphoma: Role of low-dose radiotherapy and paired literature review

Meeting Abstract

Ma, J.; Daou, R.; Eid, J. Bou; Lee, J.; Fregonese, B.; El‐Khoury, J.; Wijetunga, N. A.; Imber, B. S.; Yahalom, J.; Hajj, C.
Hematological Oncology (2023)

Fulltext@MSK | Save

Drug‐resistance mutations in BTK occur in distinct enzymatic classes and are overcome by BTK degradation

Meeting Abstract

Montoya, S.; Bourcie, J.; Sondhi, A.; Jahn, J.; Alencar, A.; Abdel-Wahab, O.; Taylor, J.
Hematological Oncology (2023)

Fulltext@MSK | Save

Radiation in a new era of multiple myeloma management: Patterns of utilization, clinical, radiologic, and biochemical outcomes, and possible genomic correlates of response

Meeting Abstract

Dreyfuss, A. D.; Fregonese, B.; Ma, J.; Reith, S.; Cederquist, G.; Hubbeling, H.; Tringale, K. R.; Wijetunga, N. A.; Usmani, S.; Hajj, C.; more...
Hematological Oncology (2023)

Fulltext@MSK | Save

The prognostic value of progressing within 24 months of frontline chemoimmunotherapy (POD24) in relapsed/refractory (R/R) follicular lymphoma (FL)—a SCHOLAR‐5 analysis

Meeting Abstract

Patel, A. R.; Limbrick‐Oldfield, E. H.; Kanters, S.; Ray, M. D.; Best, T.; Ghione, P.; Neelapu, S. S.; Gribben, J. G.; Beygi, S.; Bobillo, S.
Hematological Oncology (2023)

Fulltext@MSK | Save

A single‐center experience of low‐dose radiotherapy for primary extranodal marginal zone lymphoma of bronchus‐associated lymphoid tissue (BALT)

Meeting Abstract

Freret, M. E.; Tringale, K. R.; Imber, B. S.; Joffe, E.; Yahalom, J.; Hajj, C.
Hematological Oncology (2023)

Fulltext@MSK | Save

Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma

Meeting Abstract

Cederquist, G.; Tringale, K.; Hajj, C.; Hubbeling, H.; Sarkar, R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Salles, G.; more...
Hematological Oncology (2023)

Fulltext@MSK | Save

PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma

Meeting Abstract

Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
Hematological Oncology (2023)

Fulltext@MSK | Save